Multidrug-resistant Salmonella Typhi among symptomatic and asymptomatic children in informal settlements in Nairobi, Kenya

  28 October 2024

Multidrug-resistant Salmonella Typhi (MDR) infections pose a significant global health concern. A study in Nairobi, Kenya, found that 215 presumed S. Typhi isolates were confirmed in symptomatic and asymptomatic children. The majority of these isolates were resistant to ampicillin, chloramphenicol, and sulfamethoxazole trimethoprim, as well as cephalosporin or fluoroquinolone. The study also found blaTEM−D, AMR genes in 84% of the isolates. The findings underscore the need for continued surveillance of antimicrobial resistance and mass immunization of children in urban informal areas.

Further reading: BMC Infectious Diseases
Author(s): Susan M. Kavai et al
Effective Surveillance   Kids and Carers  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed